The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review
Open Access
- 16 March 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (6) , 1717
Abstract
Common Variable Immunodeficiency (CVID) is a heterogeneous primary immunodeficiency disorder characterised by impaired antibody production, leading to recurrent infections and an increased susceptibility to viral pathogens. This literature review aims to provide a comprehensive overview of CVID’s relationship with viral infections, encompassing disease pathogenesis, key presenting features, specific monogenic susceptibilities, the impact of COVID-19, and existing treatment options. The pathogenesis of CVID involves complex immunological dysregulation, including defects in B cell development, antibody class switching, and plasma cell differentiation. These abnormalities contribute to an impaired humoral immune response against viral agents, predisposing individuals with CVID to a broad range of viral infections. Genetic factors play a prominent role in CVID, and monogenic drivers of CVID-like disease are increasingly identified through advanced genomic studies. Some monogenic causes of the CVID-like phenotype appear to cause specific viral susceptibilities, and these are explored in the review. The emergence of the COVID-19 pandemic highlighted CVID patients’ heightened predisposition to severe outcomes with viral infections. This review explores the clinical manifestations, outcomes, and potential therapeutic approaches for COVID-19 in CVID patients. It assesses the efficacy of prophylactic measures for COVID-19, including vaccination and immunoglobulin replacement therapy, as well as trialled therapies.Keywords
This publication has 242 references indexed in Scilit:
- COVID‐19 infection in CVID patients: What we know so farImmunity, Inflammation and Disease, 2021
- Norovirus antivirals: Where are we now?Medicinal Research Reviews, 2018
- Role of Immunoglobulin Therapy to Prevent and Treat Infections2018
- Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent RecurrencesJAMA, 2016
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalenceHepatology, 2013
- European Surveillance of Immunoglobulin Safety—Results of Initial Survey of 1243 Patients with Primary Immunodeficiencies in 16 CountriesClinical Immunology, 2002
- Outcome of Intravenous Immunoglobulin-Transmitted Hepatitis C Virus Infection in Primary ImmunodeficiencyClinical Immunology, 2001
- Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphomaSeminars in Cancer Biology, 2000
- Common Variable Immunodeficiency: Clinical and Immunological Features of 248 PatientsClinical Immunology, 1999
- Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulinAmerican Journal of Hematology, 1999